Concepedia

Snezana Milutinovic

SM

Statistics

Publications

16

Citations

2.5K

H-Index

14

Active since

2000

Affiliations

McGill University(Current)

Montreal Neurological Institute and Hospital

Aegera Therapeutics (Canada)

Sierra Wireless (Canada)

Sanford Burnham Prebys Medical Discovery Institute

Snezana Milutinovic is an author at McGill University specializing in life sciences, molecular oncology, and molecular biology.

Publications per year

2000–2024

16

Publications

16

cIAP1 and cIAP2 Facilitate Cancer Cell Survival by Functioning as E3 Ligases that Promote RIP1 Ubiquitination

Mathieu J.M. Bertrand, Snezana Milutinovic, Kathleen M. Dickson et al. · Molecular Cell · 2008 · 1.1K citations

Life Sciences, Cancer Biology, Molecular Biology +13

Valproate induces widespread epigenetic reprogramming which involves demethylation of specific genes

Snezana Milutinovic, Ana C. D’Alessio, Nancy Detich et al. · Carcinogenesis · 2006 · 256 citations

Life Sciences, Molecular Biology, Pharmacology +16

ARX788, a Site-specific Anti-HER2 Antibody–Drug Conjugate, Demonstrates Potent and Selective Activity in HER2-low and T-DM1–resistant Breast and Gastric Cancers

Lillian Skidmore, Sukumar Sakamuri, Nick Knudsen et al. · Molecular Cancer Therapeutics · 2020 · 160 citations

Pharmacy, Medicinal Chemistry, Oncology +17

XIAP variants in male Crohn's disease

Britt‐Sabina Petersen, Snezana Milutinovic, Esther Bosse et al. · Gut · 2014 · 155 citations · Full text

Life Sciences, Immunology, Molecular Genetics +17

Combination Treatment of the Oral CHK1 Inhibitor, SRA737, and Low-Dose Gemcitabine Enhances the Effect of Programmed Death Ligand 1 Blockade by Modulating the Immune Microenvironment in SCLC

Triparna Sen, Carminia Maria Della Corte, Snezana Milutinovic et al. · Journal of Thoracic Oncology · 2019 · 119 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 16